Literature DB >> 20359286

An update on drug interactions with the herbal medicine Ginkgo biloba.

María José Abad1, Luis Miguel Bedoya, Paulina Bermejo.   

Abstract

Medicinal plants are gaining in popularity due to the various advantages they offer, such as fewer side-effects, better patient compliance, relatively low cost and high accessibility as well as their high acceptability due to a long history of use. There is a widespread belief among the general public that herbal preparations are "good for humans" as they are "all natural". However, the increasing use of herbal medicinal products in the community where people are also receiving prescription medicines suggests that adverse herb-drug interactions may be have significant public health consequences. There is little understanding or appreciation of the fact that these "all natural" preparations are actually a combination of potentially biologically active compounds already existing in marketed products in unknown quantities. Among the most popular herbal products used worldwide is Ginkgo biloba, used for the treatment of cerebral insufficiency, peripheral vascular diseases, and frequently taken for the enhancement of memory function. Although the safety of Ginkgo biloba is promising, accumulated data show evidence of significant interactions with medications, which can place individual patients at great risk. In this review, we examined the literature from 2000 to 2008 and focused on the importance of the risk of drug interactions and potential side effects when Ginkgo biloba is involved. The aim of this systematic review is to assess the clinical evidence on interactions between Ginkgo biloba and drugs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20359286     DOI: 10.2174/138920010791110818

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  6 in total

1.  Effect of ginkgo biloba on the pharmacokinetics of raltegravir in healthy volunteers.

Authors:  Maren Blonk; Angela Colbers; Anne Poirters; Bas Schouwenberg; David Burger
Journal:  Antimicrob Agents Chemother       Date:  2012-07-16       Impact factor: 5.191

2.  Terpinolene, a component of herbal sage, downregulates AKT1 expression in K562 cells.

Authors:  Naoko Okumura; Hitomi Yoshida; Yuri Nishimura; Yasuko Kitagishi; Satoru Matsuda
Journal:  Oncol Lett       Date:  2011-11-18       Impact factor: 2.967

3.  Effects of Gingko biloba extract on tissue distribution of fluoxetine and venlafaxine in rats.

Authors:  Saad Abdulrahman Hussain; Fatima Adnan Alzubaidi; Hayder Obayes Hashem
Journal:  J Intercult Ethnopharmacol       Date:  2015-06-30

4.  Determination of the Awareness about and Need for Health Support Pharmacies as the Provider of Consultation Service about Nutrition Education and Diet-Related Health Promotion by Health Professionals in Japan.

Authors:  Tsuyoshi Chiba; Nanae Tanemura; Chiharu Nishijima
Journal:  Nutrients       Date:  2021-12-30       Impact factor: 5.717

Review 5.  Ginkgo biloba in the management of the COVID-19 severity.

Authors:  Hayder M Al-Kuraishy; Ali I Al-Gareeb; Ajeet Kaushik; Małgorzata Kujawska; Gaber El-Saber Batiha
Journal:  Arch Pharm (Weinheim)       Date:  2022-06-07       Impact factor: 4.613

Review 6.  A regulatory science viewpoint on botanical-drug interactions.

Authors:  Manuela Grimstein; Shiew-Mei Huang
Journal:  J Food Drug Anal       Date:  2018-02-15       Impact factor: 6.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.